Pearson Research & Development Limited

Other

Maurine Pearson

Teresa Leigh Barr

A formula for use in treating skin aliments includes from about 20 to about 75 wt % emu oil; from about 0.10 to 33 wt % benzyl alcohol; from about 0.10 to about 33 wt % benzoin derivative; from about 0.2 to about 2 wt % allantoin; from about 0.25 to about 1.25 wt % methylparaben; from about 1.0 to about 13 wt % alkyl esters; and from about 0.01 to about 0.30 wt % propylparaben. The formula can be applied to skin of animals or humans with skin ailments. The formula can be applied is various manners, such as through an enhanced oil, a spray, an elastomeric device, a wipe, a lotion, an ointment, a cream, a gel or combinations thereof.

Emu-based formulations for the treatment of damaged skin by inhibiting microbial and fungal activity

The present formulation is an analgesic, anesthetic and anti-pruritic formulation with from about 10.0 wt % to about 75.0 wt % Emu oil; from about 10.0 wt % to about 33.0 wt % benzyl alcohol; from about 0.25 wt % to about 5.0 wt % allantoin; from about 0.1 wt % to about 5.0 wt % methylparaben; from about 0.1 wt % to about 2.0 wt % propylparaben; and from about 0.5 wt % to about 4.0 wt % of lidocaine, wherein the formulation is adapted to inhibit microbial activity fromor combinations thereof, and wherein the lidocaine relieves pain on the epidermis of humans and animals of skin irritations, wounds, or burns.

Emu-based formulations with lidocaine for wound treatment by inhibiting microbial activity

The invention is a method and supplement for treatment of symptoms of Alzheimer's disease, dementia, depression, and combination thereof, comprising: from about 20 wt % to about 70 wt % emu oil, wherein the emu oil further comprises from about 1 wt % to about 12 wt % linolenic acid; from about 5 wt % to about 30 wt % l-arginine; from about 5 wt % to about 30 wt % pyroglutamate; from about 0.5. wt % to about 20 wt % B-12 methylcobalamin; and from about 0.5 wt % to about 20 wt % calcium, wherein the supplement is adapted for crossing a blood brain barrier, and for fortification of phospholipids in neurotransmitters of a brain to increase cell proliferation for treatment of symptoms of Alzheimer's disease, dementia, depression, and combinations thereof.

Emu-based compositions for mental well-being and method of use

An analgesic, anesthetic and antipruritic formulation is provided containing 0.01 to 13 wt % alkyl esters; and 20 to 70 wt % Emu oil; 10 to 33 wt % benzyl alcohol; 10 to 33 wt % benzoin; 0.2 to 2 wt % allantoin; 0.25 to 1.25 wt % methylparaben and 0.01 to 0.30 wt % propylparaben. The formulation may be formulated as a spray or transdermal formula. The formulation may be used for treatment of chronic cutaneous ulcers and burn wounds.

Growing community of inventors

Pilot Point, TX, United States of America

Maurine Pearson